Related Experiment Video
Updated: Jul 8, 2026

09:45
An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells
Published on: May 21, 2019
Microarray technologies for gene transcript analysis in pancreatic cancer
C P Kolbert1, C P Kolbert, S Chari
1Clinical Research Unit, Mayo Clinic, Rochester, MN 55905, USA.
Technology in Cancer Research & Treatment
|January 18, 2008
Summary
This review explores how DNA microarray analysis can identify biomarkers for early pancreatic cancer detection and treatment. Gene transcript measurements offer hope for improving patient outcomes in this challenging disease.
Area of Science:
- Oncology
- Molecular Biology
- Biotechnology
Background:
- Pancreatic cancer presents a significant health challenge with a generally poor prognosis.
- Early diagnosis and effective chemotherapeutic interventions are crucial for improving patient outcomes.
- Microarray technologies offer a promising avenue for identifying diagnostic and therapeutic markers.
Purpose of the Study:
- To review the current applications of DNA microarray analysis in pancreatic cancer research.
- To highlight the role of gene transcript level measurement in identifying potential biomarkers.
- To discuss the implications for early diagnosis and chemotherapeutic strategies.
Main Methods:
- Review of current scientific literature on pancreatic cancer and microarray technology.
- Analysis of studies measuring gene transcript levels using DNA microarrays.
- Synthesis of findings related to biomarker identification.
Main Results:
- Microarray analysis is a key technology for profiling gene expression in pancreatic cancer.
- Identification of potential gene expression markers associated with early diagnosis.
- Gene transcript data can inform the selection of chemotherapeutic targets.
Conclusions:
- DNA microarray analysis is a valuable tool in advancing pancreatic cancer research.
- Further research utilizing microarrays can lead to improved diagnostic and therapeutic strategies.
- Gene transcript profiling holds potential for transforming pancreatic cancer management.

